J&J, Bavarian Nordic start clinical tests in Ebola vaccine race

January 6, 2015 12:37 PM

7
0

LONDON (Reuters) - Johnson & Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing.

The initiation of the Phase I study in Britain, which had been expected about now, marks further progress in the race to develop a vaccine against a disease that has killed more than 8,000 people in West Africa since last year.